Lase Innovation Inc.

Lase Innovation Inc. is a for-profit biotechnology company that specializes in developing advanced flow cytometry and single-cell analysis technologies. The company has been registered to receive federal awards since March 2019 and has secured multiple grants from the National Institutes of Health (NIH) to support its innovative research and development efforts. Lase Innovation Inc. focuses on creating novel tools and methods that enable researchers to conduct more comprehensive and efficient studies of cellular behavior, particularly in the fields of immunology, cancer research, and drug discovery.

Through its federal grant awards, Lase Innovation Inc. has pursued several groundbreaking projects aimed at enhancing the capabilities of flow cytometry and single-cell analysis. These include the development of a DNA-optical barcoding technology for spatiotemporal single-cell analysis, funded by the National Human Genome Research Institute, which allows for the integration of live-cell imaging and high-throughput single-cell sequencing. The company has also received funding from the National Cancer Institute to create a time-lapse flow cytometry method for kinetic profiling of T-cell function, which aims to accelerate the development of more effective cancer immunotherapies. Additionally, Lase Innovation Inc. has worked on projects to improve the throughput of flow cytometry for drug screening applications and to develop a cyclic flow cytometry approach for ultra-high marker single-cell analysis, both funded by the National Institute of General Medical Sciences. These projects demonstrate the company's commitment to advancing the field of single-cell analysis and its potential to contribute significantly to both basic research and clinical applications in areas such as cancer biology, immunology, and drug discovery.